Fierce BD&L Summit for Life Sciences
Evvnt Promotion / evvnt
Archivo
15.03.2022 - 16.03.2022 Hyatt Centric Fisherman's Wharf San Francisco, 555 North Point Street, 94133 San Francisco, USA
Time: 8:00 AM - 5:00 PM
Temas de la conferencia
Despite the challenges of the past few years, 2021 saw a continued return to normal deal-making activity in the life sciences sector as pharma and biotech companies quickly adapted and readjusted their business goals leading to a reinvigorated marketplace ripe with new opportunities but also with new challenges and risks. Now is the ideal time for life sciences companies to capitalize on the innovation and investment opportunities in the industry and build a comprehensive business development.
Despite the challenges of the past few years, 2021 saw a continued return to normal deal-making activity in the life sciences sector as pharma and biotech companies quickly adapted and readjusted their business goals leading to a reinvigorated marketplace ripe with new opportunities but also with new challenges and risks. Now is the ideal time for life sciences companies to capitalize on the innovation and investment opportunities in the industry and build a comprehensive business development.
Organizador profesional (PCO)
Fierce Pharma & Fierce Biotech
Fierce Pharma & Fierce Biotech
Información e inscripción:
https://go.evvnt.com/963978-2?pid=4832
Mr. Richard Watanabe
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
Fierce BD&L Summit for Life Sciences: USD 1595.00
Fierce BD&L Summit for Life Sciences: USD 1595.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
